Air pollution and survival in patients with malignant mesothelioma and asbestos-related lung cancer: a follow-up study of 1591 patients in South Korea
- PMID: 38858710
- PMCID: PMC11163745
- DOI: 10.1186/s12940-024-01094-y
Air pollution and survival in patients with malignant mesothelioma and asbestos-related lung cancer: a follow-up study of 1591 patients in South Korea
Abstract
Background: Despite significant advancements in treatments such as surgery, radiotherapy, and chemotherapy, the survival rate for patients with asbestos-related cancers remains low. Numerous studies have provided evidence suggesting that air pollution induces oxidative stress and inflammation, affecting acute respiratory diseases, lung cancer, and overall mortality. However, because of the high case fatality rate, there is limited knowledge regarding the effects of air pollution exposures on survival following a diagnosis of asbestos-related cancers. This study aimed to determine the effect of air pollution on the survival of patients with malignant mesothelioma and asbestos-related lung cancer.
Methods: We followed up with 593 patients with malignant mesothelioma and 998 patients with lung cancer identified as asbestos victims between 2009 and 2022. Data on five air pollutants-sulfur dioxide, carbon monoxide, nitrogen dioxide, fine particulate matter with a diameter < 10 μm, and fine particulate matter with a diameter < 2.5 μm-were obtained from nationwide atmospheric monitoring stations. Cox proportional hazard models were used to estimate the association of cumulative air pollutant exposure with patient mortality, while adjusting for potential confounders. Quantile-based g-computation was used to assess the combined effect of the air pollutant mixture on mortality.
Results: The 1-, 3-, and 5-year survival rates for both cancer types decreased with increasing exposure to all air pollutants. The estimated hazard ratios rose significantly with a 1-standard deviation increase in each pollutant exposure level. A quartile increase in the pollutant mixture was associated with a 1.99-fold increase in the risk of malignant mesothelioma-related mortality (95% confidence interval: 1.62, 2.44). For lung cancer, a quartile increase in the pollutant mixture triggered a 1.87-fold increase in the mortality risk (95% confidence interval: 1.53, 2.30).
Conclusion: These findings support the hypothesis that air pollution exposure after an asbestos-related cancer diagnosis can negatively affect patient survival.
Keywords: Air pollution; Exposure mixtures; Lung cancer; Malignant mesothelioma; Survival analysis.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures


Similar articles
-
Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM2.5, BC, NO2, and O3: An Analysis of European Cohorts in the ELAPSE Project.Res Rep Health Eff Inst. 2021 Sep;2021(208):1-127. Res Rep Health Eff Inst. 2021. PMID: 36106702 Free PMC article.
-
Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.Res Rep Health Eff Inst. 2009 Mar;(139):5-71; discussion 73-89. Res Rep Health Eff Inst. 2009. PMID: 19554969
-
Mortality-Air Pollution Associations in Low Exposure Environments (MAPLE): Phase 2.Res Rep Health Eff Inst. 2022 Jul;2022(212):1-91. Res Rep Health Eff Inst. 2022. PMID: 36224709 Free PMC article.
-
Association between exposure to ambient air pollution and hospital admission, incidence, and mortality of stroke: an updated systematic review and meta-analysis of more than 23 million participants.Environ Health Prev Med. 2021 Jan 26;26(1):15. doi: 10.1186/s12199-021-00937-1. Environ Health Prev Med. 2021. PMID: 33499804 Free PMC article.
-
The Impact of Ambient Environmental and Occupational Pollution on Respiratory Diseases.Int J Environ Res Public Health. 2022 Feb 27;19(5):2788. doi: 10.3390/ijerph19052788. Int J Environ Res Public Health. 2022. PMID: 35270479 Free PMC article. Review.
Cited by
-
Depressive and Anxiety Symptoms Among Patients with Asbestos-Related Diseases in Korea.Toxics. 2025 Aug 21;13(8):703. doi: 10.3390/toxics13080703. Toxics. 2025. PMID: 40863979 Free PMC article.
-
Molecular Insights into Pleural Mesothelioma: Unveiling Pathogenic Mechanisms and Therapeutic Opportunities.Diagnostics (Basel). 2025 May 24;15(11):1323. doi: 10.3390/diagnostics15111323. Diagnostics (Basel). 2025. PMID: 40506895 Free PMC article. Review.
-
Malignant Mesothelioma: Overcoming Diagnostic Hurdles.Cureus. 2024 Sep 5;16(9):e68718. doi: 10.7759/cureus.68718. eCollection 2024 Sep. Cureus. 2024. PMID: 39371847 Free PMC article.
-
Immunotherapy for lung adenocarcinoma patients with bone metastases: who really needs it.Front Immunol. 2024 Dec 13;15:1457916. doi: 10.3389/fimmu.2024.1457916. eCollection 2024. Front Immunol. 2024. PMID: 39735542 Free PMC article.
References
-
- Han Y, Zhang T, Chen H, Yang X. Global magnitude and temporal trend of mesothelioma burden along with the contribution of occupational asbestos exposure in 204 countries and territories from 1990 to 2019: results from the global burden of Disease Study 2019. Crit Rev Oncol/Hematol. 2022;179:103821. doi: 10.1016/j.critrevonc.2022.103821. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical